£515.00

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India

Subjects

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£515 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price

Price Analysis

Most common price: £515 (73 days, 100.0%)

Price range: £515 - £515

Price levels: 1 different prices over 73 days

Description

This study covers the latent demand outlook for peripheral neuropathy treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for peripheral neuropathy treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of peripheral neuropathy treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Assertio Therapeutics, Baxter International, Biogen, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B0BGKZ8YX5
Category: Books > Subjects
Domain: Amazon UK
Release Date: 14 September 2022
Listed Since: 29 September 2022

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in China

The 2026-2031 World Outlook for Peripheral Neuropathy Treatments

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

The 2026-2031 World Outlook for Peripheral Neuritis Treatments

The 2023-2028 Outlook for Diabetic Neuropathy in the United States

Peripheral Neuropathy - Causes, Symptoms, and Treatment Options

Peripheral Neuropathy - Advances in Diagnostic and Therapeutic Approaches

The 2023-2028 Outlook for Diabetic Neuropathy in India

The 2023-2028 Outlook for Nerve Repair and Regeneration in India

Peripheral Neuropathies, An Issue of Neurologic Clinics (Volume 43-4) (The Clinics: Internal Medicine, Volume 43-4)

Peripheral Neuropathy

Peripheral Neuropathy and Neuropathic Pain

The 2026-2031 World Outlook for Peripheral Nerve Stimulators

The 2021-2026 World Outlook for Nerve Repair and Regeneration

The 2025-2030 World Outlook for Diabetic Neuropathy

The 2023-2028 Outlook for Diabetic Neuropathy in China

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in India

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in the United States

Neuropathies périphériques (Volume 1): Moyens d'explorations, évaluations et classifications

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan

Basic Principles of Peripheral Nerve Disorders

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States